The Conquer Cancer®, the ASCO Foundation and Pfizer Inc. are collaborating to offer a Quality Improvement grant funding opportunity for healthcare systems, hospitals, cancer centers and other patient care delivery organizations to leverage digital technology to improve evidence-based biomarker testing and treatment practices, with a focus on colorectal, lung, and/or prostate cancer.
Donor Name: Pfizer
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 10/16/2025
Size of the Grant: $100,000 to $500,000
Grant Duration: 1 Year
Details:
This RFP intends to fund novel technology-centric quality improvement projects that identify gaps in actionable biomarker testing and targeted therapy and work to address those gaps. Proposals may have a pan-tumor focus but should include at least one of the following cancer types:
- Colorectal Cancer
- Prostate Cancer
- Non-small cell lung cancer (NSCLC)
Areas of Interest
The underuse of or delays in the turnaround time of key diagnostic tests prevents patients from receiving the best care. This RFP will fund practice-based QI projects that will use evidencebased standards to deliver timely, high-quality, patient-centered care. This includes using a combination of technological solutions and established quality improvement approaches to close known gaps. Projects should:
- Use data to assess current levels of actionable biomarker and genetic testing and identify opportunities for improvement. Actionability means that the right test was ordered and the data was available and used to determine the treatment.
- Use data to assess the timeliness of test ordering and turn-around times and identify opportunities for improvement.
- Use data to assess adherence to guideline-based treatment plans for patients, based upon biomarker testing results and identify opportunities for improvement.
- Develop or improve the use of systematic approaches to conducting biomarker and genetic testing for patients.
- Improve access to treatment and diagnostics through improving adherence to NCCN and ASCO Guidelines.
- Implement sustainable and potentially transferable solutions that improve the quality of care.
Funding Information
This opportunity is intended to support quality improvement projects with an approximate 12- month duration, and a maximum grant budget of $250,000.
Eligibility Criteria
- The following organization types may apply: academic Institutions, healthcare systems, hospitals, cancer centers and other patient care delivery organizations.
- Only organizations are eligible to receive grants, not individuals.
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions, organizations, and associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead or an authorized designee of such an individual (e.g., the Project Lead’s grant/research coordinator).
- The Project Lead must be an employee or contractor of the requesting organization.
- For projects offering continuing education credit, the requesting organization must be the accredited provider.
For more information, visit Pfizer.
